Showing 1 - 10 of 29,364
The Covid-19 pandemic tragically emphasized severe failures of health systems. In particular, the saturation of hospital infrastructures and the lack of medical devices is crucial for respiratory ventilators. The medical and pharmaceutical sectors had to find urgently new ways to innovate...
Persistent link: https://www.econbiz.de/10014308369
). It is found that under technological proximity, competitions at the upstream stage depress R&D investment, and firms …
Persistent link: https://www.econbiz.de/10011885533
Persistent link: https://www.econbiz.de/10011702980
This paper analyzes the role of absorptive capacity in R&D spillovers through strategic R&D investments in a game-theoretic framework. In the model, a firm's effective R&D is composed of idiosyncratic R&D, which produces its own innovations, and identical R&D, which improves absorptive capacity....
Persistent link: https://www.econbiz.de/10011764985
Persistent link: https://www.econbiz.de/10012800211
Persistent link: https://www.econbiz.de/10014312894
Pharmaceutical firms spend billions of dollars to develop the next breakthrough drug and to maintain their market shares. We investigate how pharmaceutical firms use mergers and acquisitions to boost their innovation performance which has been found to result in better performance outcomes....
Persistent link: https://www.econbiz.de/10012502063
Persistent link: https://www.econbiz.de/10011430453
Persistent link: https://www.econbiz.de/10013170079
“reference mode”, determined the causal loop of the pharmaceuticals phase of PLC based on both an in-depth literature review and …
Persistent link: https://www.econbiz.de/10012801597